These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17514210)

  • 1. Patterns of nonclassical MHC antigen presentation.
    Hansen TH; Huang S; Arnold PL; Fremont DH
    Nat Immunol; 2007 Jun; 8(6):563-8. PubMed ID: 17514210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for a major histocompatibility complex class Ib-restricted T cell response.
    Hoare HL; Sullivan LC; Pietra G; Clements CS; Lee EJ; Ely LK; Beddoe T; Falco M; Kjer-Nielsen L; Reid HH; McCluskey J; Moretta L; Rossjohn J; Brooks AG
    Nat Immunol; 2006 Mar; 7(3):256-64. PubMed ID: 16474394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class Ib molecules bridge innate and acquired immunity.
    Rodgers JR; Cook RG
    Nat Rev Immunol; 2005 Jun; 5(6):459-71. PubMed ID: 15928678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
    Liu X; Zhang L; Zhang X; Yu H; Zhao X; Lu J; Qian G; Ge S
    Int J Oncol; 2007 Jun; 30(6):1389-96. PubMed ID: 17487359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural perspective on MHC class Ib molecules in adaptive immunity.
    Sullivan LC; Hoare HL; McCluskey J; Rossjohn J; Brooks AG
    Trends Immunol; 2006 Sep; 27(9):413-20. PubMed ID: 16860610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immunological synapse by membrane-bound and soluble ligands.
    González PA; Carreño LJ; Figueroa CA; Kalergis AM
    Cytokine Growth Factor Rev; 2007; 18(1-2):19-31. PubMed ID: 17344089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation and recognition in bacterial infections.
    Kaufmann SH; Schaible UE
    Curr Opin Immunol; 2005 Feb; 17(1):79-87. PubMed ID: 15653315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution.
    Huang S; Martin E; Kim S; Yu L; Soudais C; Fremont DH; Lantz O; Hansen TH
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8290-5. PubMed ID: 19416870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune interactions at the maternal-fetal interface: a focus on antigen presentation.
    Huddleston H; Schust DJ
    Am J Reprod Immunol; 2004 Apr; 51(4):283-9. PubMed ID: 15212681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
    Godfrey DI; Rossjohn J; McCluskey J
    Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell recognition of glycolipids presented by CD1 proteins.
    Young DC; Moody DB
    Glycobiology; 2006 Jul; 16(7):103R-112R. PubMed ID: 16597658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I antigens and immune surveillance in transformed cells.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
    Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Was the ancestral MHC involved in innate immunity?
    Levasseur A; Pontarotti P
    Eur J Immunol; 2010 Oct; 40(10):2682-5. PubMed ID: 21038466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation in the immune response to infectious diseases.
    Pamer EG
    Clin Infect Dis; 1999 Apr; 28(4):714-6. PubMed ID: 10825024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What guides MHC-restricted TCR recognition?
    Mazza C; Malissen B
    Semin Immunol; 2007 Aug; 19(4):225-35. PubMed ID: 17521918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural immunity has significant impact on immune responses against cancer.
    Rubin B
    Scand J Immunol; 2009 Mar; 69(3):275-90. PubMed ID: 19281540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.